Cookie and Privacy Settings

This website uses cookies to enable essential functions like the user login and sessions. We also use cookies and third-party tools to improve your surfing experience on preplounge.com. You can choose to activate only essential cookies or all cookies. You can always change your preference in the cookie and privacy settings. This link can also be found in the footer of the site. If you need more information, please visit our privacy policy.

Data processing in the USA: By clicking on "I accept", you also consent, in accordance with article 49 paragraph 1 sentence 1 lit. GDPR, to your data being processed in the USA (by Google LLC, Facebook Inc., LinkedIn Inc., Stripe, Paypal).

Manage settings individually I accept
  1. Dashboard 1
  2. Consulting Q&A 2
  3. Pharma Market Sizing 3
expert
Expert with best answer

Vlad

97% Recommendation Rate

411 Meetings

11,459 Q&A Upvotes

USD 239 / Coaching

Book a coaching
View profile of Vlad
1

Pharma Market Sizing

Healthcare healthcare pharma pharma and health care cases Pharmaceuticals

Hi! I've been applying to healthcare specific consulting firms and I realized they usually ask a bunch of market sizing questions. I was curious as to what could contribute to low diagnosis rates and low treatment rates?

Hi! I've been applying to healthcare specific consulting firms and I realized they usually ask a bunch of market sizing questions. I was curious as to what could contribute to low diagnosis rates and low treatment rates?

 Recent activity on Jun 11, 2018
4.2 k Views
1 answer
  • Upvotes
  • Date ascending
  • Date descending
Best Answer
Book a coaching with Vlad

97% Recommendation Rate

411 Meetings

11,459 Q&A Upvotes

USD 239 / Coaching

Choose a time slot
View profile of Vlad

Hi,

These are some of the factors that can limit either your addressable market or the potential market share:

  • Low diagnosis rates
  • Low treatment rates
  • Prescription vs. OTC
  • Pharmacies vs. retail restrictions for OTC
  • Competitor's patent
  • TV ad's limitations
  • Etc

Best!

Hi,

These are some of the factors that can limit either your addressable market or the potential market share:

  • Low diagnosis rates
  • Low treatment rates
  • Prescription vs. OTC
  • Pharmacies vs. retail restrictions for OTC
  • Competitor's patent
  • TV ad's limitations
  • Etc

Best!

2 Book a coaching with Vlad

Related case(s)

MBB Case: COVID-19 Vaccine

Solved 6.1k times
MBB Case: COVID-19 Vaccine The COVID-19 pandemic has killed millions of people worldwide and led to devastating economic impact. A vaccine is one of the biggest hopes for stopping the pandemic.  The World Health Organization (WHO) is working with multiple stakeholders to ensure groups at higher risk of becoming infected and dying (e.g. elderly people and healthcare workers) receive a safe an effective COVID-19 vaccine in the next six months. The WHO’s Director-General asked your help to build a plan to achieve this goal. What should be included in this plan?
4.6 5 294
| Rating: (4.6 / 5.0)
Difficulty: Advanced | Style: Interviewer-led (McKinsey style) | Topics: Market analysis, Market sizing, Operations strategy, Organizational behavior

The COVID-19 pandemic has killed millions of people worldwide and led to devastating economic impact. A vaccine is one of the biggest hopes for stopping the pandemic. The World Health Organization (WHO) is working with multiple stakeholders to ensure groups at higher risk of becoming infected and ... Open whole case

Similar questions

pharma/biotech cases
Dear PrepLounge community, would some of you have life sciences/health care case books to recommend?
Can anyone suggest the method for estimating the market size for diabetes devices?
Specialise in Digital Healthcare early on?
EY Business Consulting (Advisory) or EY Parthenon?
How do I best prepare for a BT/pharma consultancy interview? E.g. are there any specific pharma cases worth to review?
Doctor pre-MBA career advice.
Wild Card question: How would you price a COVID 19 vaccine?
Healthcare in the Middle East
Case Challenge: Pharmaceutical Company, R&D Pipeline Value, Successful Rate
Ask new question